Zacks.com on MSN

How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results?

Novo Nordisk's Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry, market limits and compounded ...
European Medical Journal

CHEST 2025: GLP-1 Receptor Agonists Cut Right Heart Failure Risk

In pulmonary arterial hypertension, GLP-1 receptor agonists significantly lowered the risk of right heart failure compared ...